Literature DB >> 23528895

Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin-ligand complexes.

Ulrich Kragh-Hansen1.   

Abstract

BACKGROUND: Human serum albumin and some of its ligand complexes possess enzymatic properties which are useful both in vivo and in vitro. SCOPE OF REVIEW: This review summarizes present knowledge about molecular aspects, practical applications and potentials of these properties. MAJOR
CONCLUSIONS: The most pronounced activities of the protein are different types of hydrolysis. Key examples are esterase-like activities involving Tyr411 or Lys199 and the thioesterase activity of Cys34. In the first case, hydrolysis involves water and both products are released, whereas in the latter cases one of the products is set free, and the other stays covalently bound to the protein. However, the modified Cys34 can be converted back to its reduced form by another compound/enzymatic system. Among the other activities are glucuronidase, phosphatase and amidase as well as isomerase and dehydration properties. The protein has great impact on the metabolism of, for example, eicosanoids and xenobiotics. Albumin with a metal ion-containing complex is capable of facilitating reactions involving reactive oxygen and nitrogen species. GENERAL SIGNIFICANCE: Albumin is useful in detoxification reactions, for activating prodrugs, and for binding and activating drug conjugates. The protein can be used to construct smart nanotubes with enzymatic properties useful for biomedical applications. Binding of organic compounds with a metal ion often results in metalloenzymes or can be used for nanoparticle formation. Because any compound acting as cofactor and/or the protein can be modified, enzymes can be constructed which are not naturally found and therefore can increase, often stereospecifically, the number of catalytic reactions. This article is part of a Special Issue entitled Serum Albumin.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Detoxification reactions; Esterase-like activity; Human serum albumin; Hydrolysis; Metalloenzymes; Prodrug activation

Mesh:

Substances:

Year:  2013        PMID: 23528895     DOI: 10.1016/j.bbagen.2013.03.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

Review 1.  Overview of Albumin and Its Purification Methods.

Authors:  Ramin Raoufinia; Ali Mota; Neda Keyhanvar; Fatemeh Safari; Sara Shamekhi; Jalal Abdolalizadeh
Journal:  Adv Pharm Bull       Date:  2016-12-22

2.  Streamlined duplex live-dead microplate assay for cultured cells.

Authors:  Bruce A Pfeffer; Steven J Fliesler
Journal:  Exp Eye Res       Date:  2017-05-30       Impact factor: 3.467

3.  Multiplex quadruple bioluminescent assay system.

Authors:  Genta Kamiya; Nobuo Kitada; Shojiro Maki; Sung Bae Kim
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

4.  Human serum albumin presents isoform variants with altered neonatal Fc receptor interactions.

Authors:  Yann Leblanc; Marie Berger; Alexander Seifert; Nicolas Bihoreau; Guillaume Chevreux
Journal:  Protein Sci       Date:  2019-11       Impact factor: 6.725

5.  Sulfation of Lower Chlorinated Polychlorinated Biphenyls Increases Their Affinity for the Major Drug-Binding Sites of Human Serum Albumin.

Authors:  Eric A Rodriguez; Xueshu Li; Hans-Joachim Lehmler; Larry W Robertson; Michael W Duffel
Journal:  Environ Sci Technol       Date:  2016-05-04       Impact factor: 9.028

6.  Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin.

Authors:  Paolo Ascenzi; Loris Leboffe; Alessandra di Masi; Viviana Trezza; Gabriella Fanali; Magda Gioia; Massimo Coletta; Mauro Fasano
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Albuminoid genes: evolving at the interface of dispensability and selection.

Authors:  Alessandra Mozzi; Diego Forni; Rachele Cagliani; Uberto Pozzoli; Jacopo Vertemara; Nereo Bresolin; Manuela Sironi
Journal:  Genome Biol Evol       Date:  2014-10-27       Impact factor: 3.416

8.  Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis.

Authors:  Pik-Eu Chang; Boon-Bee George Goh; Victoria Ekstrom; Ming-Liang Ong; Chee-Kiat Tan
Journal:  World J Hepatol       Date:  2017-08-08

9.  Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis.

Authors:  Alice Gaudin; Sinda Lepetre-Mouelhi; Julie Mougin; Martine Parrod; Grégory Pieters; Sébastien Garcia-Argote; Olivier Loreau; Jordan Goncalves; Hélène Chacun; Yann Courbebaisse; Pascal Clayette; Didier Desmaële; Bernard Rousseau; Karine Andrieux; Patrick Couvreur
Journal:  J Control Release       Date:  2015-06-16       Impact factor: 9.776

Review 10.  Interactive association of drugs binding to human serum albumin.

Authors:  Feng Yang; Yao Zhang; Hong Liang
Journal:  Int J Mol Sci       Date:  2014-02-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.